Can-Fite’s new Drug Fights Diabetes-Related Erectile Dysfunction
Israel’s Can-Fite BioPharma Ltd., a biotechnology company which develops proprietary small molecule drugs for treating cancer and inflammatory diseases, reported it has received positive data regarding More...
Syneron Wins Award from NewBeauty Magazine
Israel’s Syneron Medical Ltd, a global medical aesthetic device company, has been awarded the “Best Body-Contouring Treatment” by NewBeauty Magazine in its annual Beauty Choice Awards for the More...
Israel Gives Oramed New Patent for Oral Administrations of Exenatide
The Israel Patent Office has granted Israel’s Oramed Pharmaceuticals, a developer of oral drug delivery systems, a patent for its invention, titled “Methods and Compositions for Oral Administrations More...
Teva launches generic blood pressure treatment in US
– Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) has announced : the Food and Drug Administration (FDA) approval and the launch of the generic equivalent of Diovan (Valsartan) tablets in More...
Senators Baldwin, Warren, Blast FDA’s Proposed Policy on Blood Donations
Sen. Elizabeth Warren (D-Mass.) took to Twitter on Tuesday to criticize the U.S. Food and Drug Administration’s proposed new policy on blood donations from gay men, saying that while the recommendation More...
Can-Fite Treats First Patient with New Cancer Drug
Israel’s Can-Fite BioPharma Ltd., a biotechnology company which develops proprietary small molecule drugs for treating cancer and inflammatory diseases, treated the first patient with its CF 102 in a Phase More...
FDA approves Teva allergy spray for children
– The QNASL nasal spray, approved in 2012 for adults, treats nasal symptoms of allergic rhinitis, including hay fever, in children. Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) More...
US court delays Teva launch of generic Celebrex
– Teva has lost its 180 days exclusivity for the generic version of Pfizer’s arthritis and chronic pain treatment. – The US Supreme Court of Appeal Court of Appeals has overturned the More...
Brokerage Upgrades Teva Recommendation following Copaxone Dosage Change
– “We are upgrading our recommendation for Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) from “Market perform” to “Market outperform” with a target price of More...
Oral Drug Delivery Systems Oramed Sells $5 Million in Stock to the Chinese
Israel’s Oramed Pharmaceuticals, a developer of oral drug delivery systems, confirmed that it has received $5 million in connection with the definitive agreement with Guangxi Wuzhou Pharmaceutical Co., More...